Latest News

  • RESEARCH

    27 Feb 2026

    Can AI Crack the Code on Fibrosis?

  • INNOVATION

    25 Feb 2026

    AI Unlocks the Secret to Cell Entry

  • PARTNERSHIPS

    24 Feb 2026

    U.S. Peptide Groups Form GMP Alliance

  • INVESTMENT

    23 Feb 2026

    $305mn Bet on Peptides Signals Shift in Cancer

AI-Designed Peptide Enters Late-Stage Infection Trial

White pills and capsule with thermometer on dollar notes

INNOVATION

20 Feb 2026

Peptilogics advances zaloganan into Phase 2/3 with $120mn in funding to tackle biofilm-related joint infections 

Scientists reviewing peptide research data in pharmaceutical lab

TECHNOLOGY

18 Feb 2026

Europe Boosts Peptide Output As AI Reshapes R&D

Manufacturers expand capacity for GLP-1 drugs while digital tools gain ground in discovery and early development

Peptilogics corporate logo on gradient background

INSIGHTS

16 Feb 2026

Can Peptides Crack the Biofilm Code?

An $88M raise sends Peptilogics into a pivotal trial targeting stubborn prosthetic joint infections 

Cholesterol monitor showing LDL value and downward arrow

RESEARCH

13 Feb 2026

From Daily Pills to One Genetic Fix

An early CRISPR trial cuts LDL in half, hinting at a future where cholesterol is treated once, not daily

US Food and Drug Administration headquarters sign

REGULATORY

12 Feb 2026

FDA’s Quality Revamp Could Reshape Drug Filings

FDA’s draft ICH M4Q update pushes drugmakers to prepare for globally aligned CMC submissions

Laboratory vial marked peptide held by researcher in blue gloves

INNOVATION

11 Feb 2026

Why Peptide Synthesis Is Entering the Fast Lane

Automated synthesis speeds peptide drug development, cuts solvent use, and reshapes competition across a fast-growing market

Takeda logo mounted on exterior wall of corporate building

PARTNERSHIPS

10 Feb 2026

AI Deals Reshape Drug Discovery Strategies

Takeda’s pact with Iambic reflects a wider shift to AI-led research to cut risk, shorten timelines and sharpen investment

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.